Slater Investments Boosts Stake in Alliance Pharma
Company Announcements

Slater Investments Boosts Stake in Alliance Pharma

Alliance Pharma (GB:APH) has released an update.

Slater Investments has increased its stake in Alliance Pharma PLC, crossing the notification threshold with a new total of 12% voting rights as of January 4, 2024. This significant acquisition comprises both direct and indirect voting rights, amounting to 64,825,000 voting rights within the healthcare company. The notification was completed on January 5, 2024, in London.

For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskAlliance Pharma Sees Major Share Ownership Shift
TipRanks UK Auto-Generated NewsdeskAlliance Pharma Reports Steady Growth in 2024
TipRanks UK Auto-Generated NewsdeskAlliance Pharma Announces Upcoming Financial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App